Diovan valsartan 160 mg tablets recalled for failed dissolution
One lot of Novartis Diovan (valsartan) 160 mg tablets failed to meet dissolution specifications, which means the tablets may not dissolve properly in the body. This could affect how well the medication works. The affected lot (AV5913C, expiring 6/2027) was distributed nationwide.
From the FDA notice · Read the official notice ↗
What to do
- Check your Diovan bottle for lot number AV5913C and expiration date of 6/2027.
- If you have this lot, contact your pharmacy or doctor before stopping your medication.
- Do not stop taking your blood pressure medication without medical guidance.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Illnesses reported
- None reported
- Manufactured in
- 1 Health Plz, East Hanover, NJ, United States
- Classification
- Class II
- Recall number
- D-0746-2026
In the FDA's words
- Description
- Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34 Failed Dissolution Specifications Lot AV5913C, Expiry: 6/2027 Distribution: US Nationwide
- Hazard
- Failed Dissolution Specifications